Massaro Fulvio, Corrillon Florent, Stamatopoulos Basile, Meuleman Nathalie, Lagneaux Laurence, Bron Dominique
PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Department of Hematology, Jules Bordet Institute (ULB), 1000 Brussels, Belgium.
Cancers (Basel). 2020 Dec 29;13(1):68. doi: 10.3390/cancers13010068.
Aging of bone marrow is a complex process that is involved in the development of many diseases, including hematologic cancers. The results obtained in this field of research, year after year, underline the important role of cross-talk between hematopoietic stem cells and their close environment. In bone marrow, mesenchymal stromal cells (MSCs) are a major player in cell-to-cell communication, presenting a wide range of functionalities, sometimes opposite, depending on the environmental conditions. Although these cells are actively studied for their therapeutic properties, their role in tumor progression remains unclear. One of the reasons for this is that the aging of MSCs has a direct impact on their behavior and on hematopoiesis. In addition, tumor progression is accompanied by dynamic remodeling of the bone marrow niche that may interfere with MSC functions. The present review presents the main features of MSC senescence in bone marrow and their implications in hematologic cancer progression.
骨髓老化是一个复杂的过程,与包括血液系统癌症在内的多种疾病的发生发展有关。年复一年,该研究领域所取得的成果突显了造血干细胞与其周围环境之间相互作用的重要作用。在骨髓中,间充质基质细胞(MSC)是细胞间通讯的主要参与者,根据环境条件,具有广泛的功能,有时甚至相互对立。尽管这些细胞因其治疗特性而受到积极研究,但其在肿瘤进展中的作用仍不清楚。原因之一是MSC的老化直接影响其行为和造血功能。此外,肿瘤进展伴随着骨髓微环境的动态重塑,这可能会干扰MSC的功能。本综述介绍了骨髓中MSC衰老的主要特征及其对血液系统癌症进展的影响。